Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells

Planta Medica

Volumn 75, Issue 11, 2009, Pages 1227-1230

  Miksits, Michaela ^a   Wlcek, Katrin ^a   Svoboda, Martin ^b   Kunert, Olaf ^c   Haslinger, Ernst ^c   Thalhammer, Theresia ^b   Szekeres, Thomas ^b   Jäger, Walter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

3,4 ,5 trihydroxy transstilbene; Cancer cell lines; Cytotoxicity; Metabolites; Resveratrol

Indexed keywords

DRUG METABOLITE; PHENOL DERIVATIVE; RESVERATROL; SULFURIC ACID; TRANS RESVERATROL 3 O 4' O DISULFATE; TRANS RESVERATROL 3 O SULFATE; TRANS RESVERATROL 4' O SULFATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER INHIBITION; CELL IMMORTALIZATION; CELL STRAIN MCF 7; CIRCULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EFFECT; DRUG GLUCURONIDATION; DRUG POTENCY; DRUG SULFATION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE; LIQUID CHROMATOGRAPHY; LIVER; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; STILBENES;

VITACEAE;

EID: 70350764804     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185533     Document Type: Article

References (25)

1. Burns J, Yokota T, Ashihara H, LeanME, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem 2002; 50: 3337-3340
2. Vastano BC, Chen Y, Zhu N, Ho CT, Zhou Z, Rosen RT. Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum. J Agric Food Chem 2000; 48: 253-256
3. Frémont L, Belguendouz L, Delpal S. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci 1999; 64: 2511-2521
4. Zou JG, Huang YZ, Chen Q,Wei EH, Hsieh TC, Wu JM. Resveratrol inhibits copper ioninduced and azo compound-initiated oxidative modification of human low density lipoprotein. Biochem Mol Biol Int 1999; 47: 1089-1096
5. Murias M, Handler N, Erker T, Pleban K, Ecker G, Saiko P, Szekeres T, Jäger W. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 2004; 12: 5571-5578
6. Murias M, Jäger W, Handler N, Erker T, Horvath Z, Szekeres T, Nohl H, Gille L. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem Pharmacol 2005; 69: 903-912
7. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Famsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-220
8. Ragione FD, Cucciola V, Borriello A, Pietra VD, Racioppi L, Soldati G,Manna C, Galleti P, Zappia V. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun 1998; 250: 53-58
9. Saiko P, Pemberger M, Horvath Z, Savinc I, Grusch M, Handler N, Erker T, Jaeger W, Fritzer-Szekeres M, Szekeres T. Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity. Oncol Rep 2008; 19: 1621-1626
10. Levi F, Pasche C, Lucchini F, Guidoni R, Ferrarono M, La VC. Resveratrol and breast cancer risk. Eur J Cancer Prev 2005; 14: 139-142
11. Walle T, Hsieh F, DeLegge MH, Oatis Jr JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004; 32: 1377-1382
12. Burkon A, Somoza V. Quantification of free and protein-bound transresveratrol metabolites and identification of trans-resveratrol-C/ Oconjugated diglucuronides - two novel resveratrol metabolites in human plasma. Mol Nutr Food Res 2008; 52: 549-557
13. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linkedrat model. J Pharmacol Exp Ther 2002; 302: 369-373
14. Maier-Salamon A, Hagenauer B, Wirth M, Gabor F, Szekeres T, Jäger W. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation ofmetabolites. Pharm Res 2006; 23: 2107-2115
15. Miksits M, Maier-Salamon A, Aust S, Thalhammer T, Reznicek G, Kunert O, Haslinger E, Szekeres T, Jaeger W. Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 2005; 35: 1101-1119
16. Murias M, Miksits M, Aust S, Spatzenegger M, Thalhammer T, Szekeres T, Jaeger W. Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Lett 2008; 261: 172-182
17. Kawai N, Fujibayashi Y, Kuwabara S, Takao K, Ijuin Y, Kobayashi S. Synthesis of a potential key intermediate of akaterpin, specific inhibitor of PI-PLC. Tetrahedron 2000; 56: 6467-6478
18. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB. Human, rat, and mouse metabolism of resveratrol. Pharm Res 2002; 19: 1907-1914
19. Wenzel E, Soldo T, Erbersdobler H, Somoza V. Bioactivity andmetabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res 2005; 49: 482-494
20. Worland PJ, Kaur G, Stetler-Stevenson M, Sebers S, Sartor O, Sausville EA. Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity. Biochem Pharmacol 1993; 46: 1831-1840
21. Carlson BA, Dubay MM, Sausville EA, Brizuela L,Worland PJ. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res 1996; 56: 2973-2978
22. Wang LX, Heredia A, Song H, Zhang Z, Yu B, Davis C, Redfield R. Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity. J Pharm Sci 2004; 93: 2448-2457
23. Pasqualini JR, Chetrite GS. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 2005; 93: 221-236
24. Ghosh D. Human sulfatases: a structural perspective to catalysis. Cell Mol Life Sci 2007; 64: 2013-2022
25. Utsumi T, Yoshimura N, Takeuchi S, Maruta M, Maeda K, Harada N. Elevated steroid sulfatase expression in breast cancers. J Steroid Biochem Mol Biol 2000; 73: 141-145